The facility is the company's first outside of the U.S. It boosts 10x Genomics' capacity for the development and marketing of single-cell and spatial analysis products. The new facility consists of more than 53,000 square feet in the Solaris@Kallang 164 complex, which includes automated production rooms for reagent manufacturing, a biosafety level 2 lab, a distribution center, warehouse space, and office areas.

10x Genomics reports revenue gains in Q2
10x Genomics reported revenue growth in the second quarter of 2021 of 170% over the same quarter a year ago.

10x Genomics inks license deal with Bio-Rad
10x Genomics and Bio-Rad Laboratories have settled their legal dispute and signed a global settlement and cross-license agreement.

10x Genomics launches FFPE Visium assay for research use
10x Genomics has launched its new Visium Spatial Gene Expression assay for formalin-fixed, paraffin-embedded (FFPE) samples, which gives researchers the...

10x Genomics launches low-throughput gene expression kit
10x Genomics has launched its chromium single-cell gene expression low-throughput kit, a new offering designed to enable single cell analysis.